Vicks Sinex Nasal Spary Bacteria Alert
The CFAI has learned today that Proctor and Gamble are recalling specific batches (Lots) of Vicks Sinex Nasal Spray because of contamination by the bacteria B. cepacia. While no specific advice has been issued by the Company in relation to Ireland, CFAI as a precaution recommends that if you have this product you should check the Lot number listed on both the outer carton and the bottle as soon as possible. If you have one of these Lots, please discard the product and let us know as soon as possible. We have alerted the HSE to this problem and sought advice from the company in relation to Ireland.
The Proctor and Gamble Press Release is as follows:
Proctor &Gamble Voluntarily Recalls Specific Lots of Vicks Sinex Nasal Spray in the United States, Germany and the United Kingdom
The company said it is taking this precautionary step after finding the bacteria B. cepacia in a small amount of product made at its plant in Gross Gerau, Germany. There have been no reports of illness. However, the bacteria could cause serious infections for individuals with a compromised immune system, or those with chronic lung conditions, such as cystic fibrosis. B. cepacia poses little medical risk to healthy individuals.
P&G detected this problem during routine quality control at the plant and promptly took action. The company's analysis to date shows this problem is limited to a single batch of raw material mixture involving three lots of product. These three lots were sold only in the United States, Germany and the United Kingdom.
The lot numbers of the products involved are:
9236028831 - United States - Vicks Sinex Vapospray 12-Hour Decongestant Ultra Fine Mist, 15ml, Nasal Spray
9224028832 - United Kingdom - Vicks Sinex Micromist Aqueous Nasal Spray Solution, 15ml
9224028833 - Germany - Wick Sinex Schnupfenspray Dosiersytem, 15ml
This lot number is listed on both the outer carton and the bottle. Consumers should simply discard the affected product as they would any OTC medicine.
P&G is removing the product in question from store shelves and has informed regulatory authorities in the affected countries. P&G said it found the bacteria B. cepacia in a small amount of product from U.S. lot 9239028831 and is conducting testing on the U.K. and German lots that have been produced from the same batch of raw material mixture.
www.uk.pg.com/news/news/VicksPressRelease19Nov09.html
« Back To News
